Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.

17 May 2010

Halozyme Therapeutics announces delivery of notice of breach to Baxter Healthcare

Halozyme Therapeutics, Inc. today announced the delivery of a notice of breach to Baxter Healthcare Corporation due to Baxter's failure to provide HYLENEX (hyaluronidase human injection) in accordance with the terms of the parties' existing development and supply contracts.

17 May 2010

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.

17 May 2010

Cell Therapeutics announces exchange agreements for 4% Convertible Senior Subordinated Notes due 2010

Cell Therapeutics, Inc. today announced that it has entered into exchange agreements with certain holders of some of the Company's outstanding 4% Convertible Senior Subordinated Notes due 2010.

17 May 2010

Astellas Pharma, OSI Pharmaceuticals sign definitive merger agreement

Astellas Pharma Inc., a global pharmaceutical company, and OSI Pharmaceuticals, Inc., a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes and obesity, today announced that they have entered into a definitive merger agreement under which Astellas will acquire OSI.

17 May 2010

Carcinogenic potential of mobile phone use not clear cut

The most comprehensive international study to date on the association between mobile phone use and brain cancers has not shown a strong causal link between the two but research on their relationship needs to continue, Professor Bruce Armstrong from the School of Public Health says.

17 May 2010

No increase in risk of glioma or meningioma with use of mobile phones: INTERPHONE project

The International Journal of Epidemiology today published a combined data analysis from a multi national population-based case-control study of glioma and meningioma, the most common types of brain tumour. This is the first in a series of combined data analyses of head and neck tumours published as part of the internationally coordinated INTERPHONE project.

17 May 2010

3SBio's first-quarter 2010 total net revenues up 40.5%

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2010.

17 May 2010

Cell Therapeutics' Special Meeting of Shareholders adjourned to June 4, 2010

Cell Therapeutics, Inc. today announced that the Company has adjourned today's Special Meeting of Shareholders to 10:00 am Pacific Daylight Time, Friday, June 4, 2010.

15 May 2010

United Spinal Association and ICS co-sponsor first annual conference to empower women with disabilities

United Spinal Association and Independence Care System (ICS), are co-sponsoring the first annual conference to improve the lives, health, and well-being of women with disabilities.

15 May 2010

Saint John's Health Center Trustee receives 2010 Distinguished Medical Science Award

Saint John's Health Center Trustee and philanthropist Patrick Soon-Shiong, M.D., who developed the first FDA-approved protein nanoparticle treatment for cancer, has received the 2010 Distinguished Medical Science Award from the Friends of the National Library of Medicine for his significant contributions to the research and treatment of diabetes and cancer.

15 May 2010

EvoLife Laboratories participates in ONS Congress 2010 to assist nurses, caregivers

EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, successfully launched its products in the USA. EvoLife Laboratories is present at the annual Oncology Nursing Society Congress 2010 in San Diego and utilizes this opportunity to further engage with nurses and caregivers.

15 May 2010

Athersys presents data supporting MultiStem programs

Athersys, Inc. today presented data supporting its MultiStem® programs in cardiovascular disease, neurological disease and immune system modulation, and highlighted advancements in other areas, including progress in its drug development program in the area of obesity.

15 May 2010

Amerigroup expands services to seniors, people with disabilities in Tarrant County

Amerigroup Corporation today announced that its Texas health plan has won its bid to expand health care coverage to seniors and people with disabilities in Tarrant County (Fort Worth). The award was announced by the Texas Health and Human Services Commission (HHSC). It came as the result of a competitive two-region bidding process that increases the role of Amerigroup's Texas subsidiary in the STAR+PLUS program.

15 May 2010

Novartis employees organise events to contribute to community organizations

In a spring tradition that has become well entrenched at the company over the past 14 years, employees of Novartis from across Canada are today joining their colleagues around the world in taking time away from their work to contribute to community organizations.

15 May 2010

Canadian cancer patients cross the border for second opinion

Two years ago, Beverlee London of Toronto was diagnosed with Stage I lung cancer. London was given the news by her lung specialist in Toronto that she had a malignant tumor on her right lung. She also decided at the time to visit the Barbara Ann Karmanos Cancer Center in Detroit for a second opinion, since she had family living in the area.

15 May 2010

Biovest International announces filing of proposed Plan of Reorganization

Biovest International, Inc. today announced that the Company filed its proposed Plan of Reorganization with the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division. With this filing, Biovest is positioned to emerge from Chapter 11 protection this summer as a fully restructured company.

15 May 2010

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

HistoRx , Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers.

15 May 2010

US Oncology Specialty passes VAWD accreditation program

US Oncology, Inc.'s Fort Worth, Texas distribution facility, US Oncology Specialty, LP, has once again successfully passed the National Association of Boards of Pharmacy Verified-Accredited Wholesale Distributors program's comprehensive criteria review and on-site inspection.

15 May 2010

Hospira's I.V. administration set product line to be standardized to non-DEHP

Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, will expand its commitment to non-DEHP products by transitioning customers to its portfolio of non-DEHP intravenous administration sets.

15 May 2010

Oncology News and Research

Further Reading

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Halozyme Therapeutics announces delivery of notice of breach to Baxter Healthcare

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

Cell Therapeutics announces exchange agreements for 4% Convertible Senior Subordinated Notes due 2010

Astellas Pharma, OSI Pharmaceuticals sign definitive merger agreement

Carcinogenic potential of mobile phone use not clear cut

No increase in risk of glioma or meningioma with use of mobile phones: INTERPHONE project

3SBio's first-quarter 2010 total net revenues up 40.5%

Cell Therapeutics' Special Meeting of Shareholders adjourned to June 4, 2010

United Spinal Association and ICS co-sponsor first annual conference to empower women with disabilities

Saint John's Health Center Trustee receives 2010 Distinguished Medical Science Award

EvoLife Laboratories participates in ONS Congress 2010 to assist nurses, caregivers

Athersys presents data supporting MultiStem programs

Amerigroup expands services to seniors, people with disabilities in Tarrant County

Novartis employees organise events to contribute to community organizations

Canadian cancer patients cross the border for second opinion

Biovest International announces filing of proposed Plan of Reorganization

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

US Oncology Specialty passes VAWD accreditation program

Hospira's I.V. administration set product line to be standardized to non-DEHP

Cancer Research eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News